Transparency Market Research Report Added "Biodefense Market" to its database.
Albany, NY -- (SBWIRE) -- 03/08/2016 -- In the last few years, biodefense has emerged as a popular method to combat the potential negative effects of bioterrorism, which is spread by biological agents or deployed using biological weaponry. The rising threat of bioterrorism and the subsequent proliferation of disease surveillance missions have driven the market for biodefense around the world.
In its report, titled "Biodefense Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023," Transparency Market Research provides a comprehensive overview of the global market for biodefense. It covers aspects such as the market's definition, segmentation based on various parameters, and factors impacting the market's growth trajectory.
Bioterrorism refers to the deliberate release of biological agents such as viruses, bacteria, toxins, or germs, which may be naturally occurring or in modified forms, in order to disseminate infections or to cause illness or death. While these germs are often found in nature, bioterrorism makes them more virulent by enhancing their potential to spread infections or by making them drug-resistant. It is possible to disseminate these biological agents through air, water, food, or from person to person. At an initial stage, these infections can be hard to detect, since they do not show any symptoms in the first few hours or days. Biodefense has emerged as a potential solution to protect people against bioterrorism.
Request for Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5369
Biodefense is deployed in two ways. It is either used as defense against an attack on a civilian population or on a military target. Ensuring defense against attacks on civilian populations is primarily based on the detection of the infection and methods to minimize the casualties and loss of water or food.
The global market for biodefense is witnessing impressive growth prospects in response to the rising importance of disease surveillance to combat the looming threat of bioterrorism. The attack of September 11, 2001, in the U.S. was followed by the subsequent outbreak of spores, anthrax, and other severe ailments. These events exposed the vulnerability of human society to bioterrorism and made governments from across the world realize the importance of improving their public health scenario, to shorten the response time in the event of similar disasters that may occur in the future.
Funding to improve bioterrorism preparedness has enabled Public Health Service to expand the reach of their surveillance activities significantly and to effectively monitor the community's health. Such recent incidents are substantially boosting the market for biodefense, which is poised to exhibit exponential growth between 2015 and 2023. Furthermore, the recent outbreak of Ebola, Zika, and the nuclear crisis in Japan are also expected to fuel demand from the biodefense market.
Regionally, North America led the global biodefense market, followed by Europe. North America boasts enhanced lab capabilities and has successfully implemented rapid health alert systems, which aid the expansion of the biodefense market in the region. However, Asia Pacific is likely to emerge as the most lucrative market for biodefense in the near future, with the region exhibiting a high adoption rate of analytical equipment and rapid development of the biotechnology industry. The Middle East and Latin America will also emerge as prospective markets for biodefense over the report's forecast period.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453